Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Source: CNBC Business
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at CNBC Business